twenty-one patients with primary humoral immunodeficiency were treated for 1 year with a chemically intact immunoglobulin , 300 mg/kg body weight given intravenously every 3 weeks , to compare immunoglobulin levels and clinical status with results achieved after standard treatment with intramuscular immunoglobulin given previously for 1 year .
C0021027
immunoglobulin
C0360506
intramuscular